View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
September 30, 2013

Japanese hospital to deploy Mitsubishi Electric’s proton beam therapy system

Tsuyama Chuo Hospital, led by Yoshinori Ukita, president of Tsuyama Jifu Group, in Okayama, has announced it will deploy Mitsubishi Electric’s proton beam therapy system for cancer treatment.

By admin-demo

proton therapy

Tsuyama Chuo Hospital, led by Yoshinori Ukita, president of Tsuyama Jifu Group, in Okayama, has announced it will deploy Mitsubishi Electric’s proton beam therapy system for cancer treatment.

Free Report
img

What is the Global Healthcare and Pharma Market Q2 Outlook?

Given the background of high inflation, re-emerging supply chain issues, and the widespread macro-economic implications of the Ukraine conflict, the global pharmaceutical industry is facing an entirely new set of challenges following the turbulence of the COVID-19 pandemic. GlobalData’s World Markets Healthcare (WMH) service has released its latest Q2 forecast. This report incorporates the latest thinking on the opportunities and risks this new environment presents for pharma companies. However, the pharma sector is proving resilient, and we are projecting 4.4% global growth for the year ahead. Yet it remains that the current economic picture is inverting some baseline assumptions from previous quarterly forecasts and altering which markets we expect the key growth levers to derive from. Download our latest executive summary for a snapshot view of what our clients use to formulate winning strategies.
by GlobalData
Enter your details here to receive your free Report.

This will be the ninth facility to carry the Mitsubishi Electric therapy system in Japan and the first system in the Chugoku-Shikoku region, in southern Japan.

Until now, Mitsubishi Electric has deployed systems at eight of the 11 particle therapy facilities in Japan, and treated more than 16,000 patients at these facilities.

The proton system has a new ‘universal nozzle’ with high dose-rate capability for efficient operation.

The proton beam therapy system will be part of a new treatment centre which is expected to open in March 2016.

The new proton beam cancer facility will be jointly operated with Okayama University.

Proton therapy is a type of external beam radiotherapy using ionising radiation. During treatment, a particle accelerator is used to target the tumour with a beam of protons.

Testing for the new proton therapy system is currently underway at the in-house proton beam facility at Mitsubishi Electric’s Kobe factory.

Following regulatory clearance, the company will also assist in staff training and commissioning support to facilitate the early start-up of treatment.

The Okayama University / Tsuyama Chuo Hospital Proton Beam Cancer Centre will offer proton cancer treatment through research and education. It will be led by Shigeatsu Fujiki, president of Tsuyama Chuo Hospital; Kiyoshi Morita, president of Okayama University; and Susumu Kanazawa, professor and chairman of the department of radiology, Okayama University Medical School.


Image: Rendition of the proton beam therapy system. Photo courtesy of Mitsubishi Electric Corporation.

Related Companies

Free Report
img

What is the Global Healthcare and Pharma Market Q2 Outlook?

Given the background of high inflation, re-emerging supply chain issues, and the widespread macro-economic implications of the Ukraine conflict, the global pharmaceutical industry is facing an entirely new set of challenges following the turbulence of the COVID-19 pandemic. GlobalData’s World Markets Healthcare (WMH) service has released its latest Q2 forecast. This report incorporates the latest thinking on the opportunities and risks this new environment presents for pharma companies. However, the pharma sector is proving resilient, and we are projecting 4.4% global growth for the year ahead. Yet it remains that the current economic picture is inverting some baseline assumptions from previous quarterly forecasts and altering which markets we expect the key growth levers to derive from. Download our latest executive summary for a snapshot view of what our clients use to formulate winning strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management